GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » Current Deferred Taxes Liabilities

Microba Life Sciences (ASX:MAP) Current Deferred Taxes Liabilities : A$0.02 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Microba Life Sciences Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Microba Life Sciences's current deferred tax liabilities for the quarter that ended in Dec. 2023 was A$0.02 Mil.

Microba Life Sciences Current Deferred Taxes Liabilities Historical Data

The historical data trend for Microba Life Sciences's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microba Life Sciences Current Deferred Taxes Liabilities Chart

Microba Life Sciences Annual Data
Trend Jun22 Jun23
Current Deferred Taxes Liabilities
- 0.01

Microba Life Sciences Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Current Deferred Taxes Liabilities - - - 0.01 0.02

Microba Life Sciences Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Microba Life Sciences's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Microba Life Sciences (ASX:MAP) Business Description

Traded in Other Exchanges
N/A
Address
324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome which includes delivering gut microbiome testing services globally to consumers, clinicians, and researchers. The company's segment includes Testing Services, and Research and Development.

Microba Life Sciences (ASX:MAP) Headlines

No Headlines